Stage III Ureter Cancer AJCC v8
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB12565 | Abexinostat | 1 | Completed | 1 |
| DB08875 | Cabozantinib | 1 | Active Not Recruiting | 1 |
| DB06186 | Ipilimumab | 1 | Active Not Recruiting | 1 |
| DB09035 | Nivolumab | 1 | Active Not Recruiting | 1 |
| DB09037 | Pembrolizumab | 1 | Completed | 1 |
| DB11595 | Atezolizumab | 2 | Active Not Recruiting | 2 |
| DB11945 | Avelumab | 2 | Completed | 1 |
| DB14547 | Chloride ion | 2 | Completed | 1 |
| DB00515 | Cisplatin | 2 | Completed | 1 |
| DB08871 | Eribulin | 2 | Active Not Recruiting | 1 |
| DB00530 | Erlotinib | 2 | Completed | 1 |
| DB00544 | Fluorouracil | 2 | Completed | 1 |
| DB00441 | Gemcitabine | 2 | Terminated | 1 |
| DB11997 | Interleukin-7 | 2 | Active Not Recruiting | 1 |
| DB06186 | Ipilimumab | 2 | Active Not Recruiting | 1 |
| DB00305 | Mitomycin | 2 | Completed | 1 |
| DB09035 | Nivolumab | 2 | Active Not Recruiting | 1 |
| DB09035 | Nivolumab | 2 | Recruiting | 1 |
| DB12257 | Platinum | 2 | Completed | 1 |
| DB14851 | Relatlimab | 2 | Recruiting | 1 |
| DB06273 | Tocilizumab | 2 | Active Not Recruiting | 1 |
| DB11945 | Avelumab | 3 | Active Not Recruiting | 1 |
| DB08875 | Cabozantinib | 3 | Active Not Recruiting | 1 |